Assignee
ENTASIS THERAPEUTICS LTD
GB·9 granted patents·2 pending applications·25 citations·filing 2013–2022
Top patents by PatentIndex Score
11 records- 0183US10800778B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2017·Granted Oct 13, 2020·4 cites·25 claims
- 0283US9540394B2Compounds and methods for treating bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2015·Granted Jan 10, 2017·3 cites·4 claims
- 0383US9187495B2Compounds and methods for treating bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2014·Granted Nov 17, 2015·4 cites·4 claims
- 0481US9968593B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2015·Granted May 15, 2018·4 cites·8 claims
- 0580US10376499B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2018·Granted Aug 13, 2019·3 cites·9 claims
- 0676US9309245B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2013·Granted Apr 12, 2016·4 cites·20 claims
- 0775US9839641B2Compounds and methods for treating bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2016·Granted Dec 12, 2017·1 cites·28 claims
- 0873US9623014B2β-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2016·Granted Apr 18, 2017·2 cites·22 claims
- 0957US2025352521A1Fixed dosage antibiotic compositionsENTASIS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1047US2015368266A1Chemical compounds 542ENTASIS THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 1131US10238661B2Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2015·Granted Mar 26, 2019·0 cites·6 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →